单位:[1]Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[2]The State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[3]Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China四川大学华西医院[4]Laboratory of Pulmonary Immunology and inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, China[5]Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Jilin University, Changchun 130041, Jilin, China[6]Priority Research Center for Healthy Lungs, Hunter Medical Research Institute, The University of Newcastle, Callaghan, Australia[7]School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, NSW, Australia[8]Centre for Inflammation, Centenary Institute, Camperdown, NSW Australia[9]Programme in Emerging Infectious Diseases, Duke-National University of Singapore Medical School, Singapore[10]Department of Pathogen Biology, Basic Medical College, Jilin University, Changchun, 130021, Jilin, China[11]Respiratory Division of Zhongshan Hospital, Shanghai Institute of Respiratory Disease, Fudan University, Shanghai, P.R.China[12]School of Life Sciences, University of Technology Sydney, Ultimo, NSW, Australia[13]Woolcock Institute of Medical Research, The University of Sydney, NSW, Australia[14]Department of Respiratory and Critical Care Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, P.R.China内科学系呼吸内科华中科技大学同济医学院附属同济医院[15]Department of Respiratory and Critical Care Medicine, Xiangya Hospital, Central South University, Changsha, China[16]Respiratory Microbiome Laboratory, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, China[17]National Health and Medical Research Council Center for Research Excellence in Severe Asthma and Treatable Traits, The University of Newcastle, Newcastle, NSW, Australia[18]Department of Respiratory and Sleep Medicine, John Hunter Hospital, Hunter Medical Research Institute, Newcastle, NSW, Australia
This study was supported by the National Natural Science Foundation of China (81920108002,
82370044, 82100032, and 82200037), Post-Doctor Research Project, West China Hospital,
Sichuan University (2021HXBH013 and 2023HXBH093), the China Postdoctoral Science
Foundation (2022M722294), and the Science and Technology Agency of Sichuan Province (No.
2022YFS0263).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类|2 区医学
小类|2 区免疫学3 区过敏
最新[2025]版:
大类|2 区医学
小类|2 区免疫学3 区过敏
第一作者:
第一作者单位:[1]Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, China[2]The State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China[3]Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, China[4]Laboratory of Pulmonary Immunology and inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, China[2]The State Key Laboratory of Respiratory Health and Multimorbidity, West China Hospital, Sichuan University, Chengdu 610041, China[4]Laboratory of Pulmonary Immunology and inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu 610041, China[*1]Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
Huang Dan,Zhang Li,Liu Ying,et al.Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma[J].Annals Of Allergy, Asthma & Immunology : Official Publication Of The American College Of Allergy, Asthma, & Immunology.2024,doi:10.1016/j.anai.2024.03.009.
APA:
Huang Dan,Zhang Li,Liu Ying,Wang Ji,Zhang Jie...&Gibson Peter G.(2024).Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.Annals Of Allergy, Asthma & Immunology : Official Publication Of The American College Of Allergy, Asthma, & Immunology,,
MLA:
Huang Dan,et al."Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma".Annals Of Allergy, Asthma & Immunology : Official Publication Of The American College Of Allergy, Asthma, & Immunology .(2024)